Clinical Trial

Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss

Study acronym: LIGHT

Terminated

View on ClinicalTrials.gov →

Why the trial stopped

Business decision.

Summary

The objective of this study is to assess the long term weight loss and weight loss journey of patients who received an Endoscopic Sleeve Gastroplasty (ESG) 5 or more years prior to enrollment.

Protocol Amendment History 10 changes

critical Trial terminated 2026-08-05

critical Trial terminated: Business decision. 2026-08-05

notable Enrollment reduced: 100 -> 2 participants 2026-08-05

notable Trial sites reduced: 8 -> 2 locations 2026-08-05

notable Primary completion moved earlier: 2026-12 -> 2026-07-30 2026-08-05

minor Completion moved earlier: 2026-12 -> 2026-07-30 2026-08-05

notable Primary completion moved earlier: 2027-01 -> 2026-12 2026-04-21

minor Completion moved earlier: 2027-01 -> 2026-12 2026-04-21

notable Primary completion pushed: 2026-12 -> 2027-01 2026-04-14

minor Completion pushed: 2026-12 -> 2027-01 2026-04-14

Trial Details

NCT Number	NCT06894498
Lead Sponsor	Boston Scientific Corporation
Conditions	Obesity and Obesity-related Medical Conditions, Weight Loss
Enrollment	2 participants
Start Date	2026-03-31
Primary Completion	2026-07-30 (estimated)
Study Completion	2026-07-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-04